Ascendis Health Limited (ASC.JO)
ZAc 78.0
(0.0%)
ZAc 78.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.47 Billion | 1.53 Billion | 1.55 Billion | 2.22 Billion | 6.96 Billion | 5.57 Billion |
| Cost of Revenue | 943.91 Million | 930.9 Million | 921.72 Million | 1.29 Billion | 3.75 Billion | 3.18 Billion |
| Gross Profit | 528.13 Million | 604.53 Million | 637.73 Million | 930.67 Million | 3.21 Billion | 2.38 Billion |
| Operating Expenses | 461.51 Million | 784.82 Million | 824.16 Million | 1.05 Billion | 2.64 Billion | 2.49 Billion |
| Selling, General and Administrative Expenses | 461.51 Million | 576.89 Million | 586.25 Million | 837.96 Million | 1.85 Billion | 1.95 Billion |
| Research and Development Expenses | - | - | - | 1.28 Million | 463 Thousand | 14.35 Million |
| Other Expenses | - | 3.57 Million | 17.23 Million | 41 Million | 18.92 Million | 52.84 Million |
| Cost and Expenses | 1.34 Billion | 1.71 Billion | 1.74 Billion | 2.34 Billion | 6.4 Billion | 5.68 Billion |
| Operating Income | 123.66 Million | -226 Million | -317.44 Million | -450.46 Million | -103.67 Million | -4.25 Billion |
| Interest Expense | 12.47 Million | 62.46 Million | 431.24 Million | 1.05 Billion | 809.52 Million | 363.57 Million |
| Income Tax Expense | -1.2 Million | 1.63 Million | -37.3 Million | 85.35 Million | -56.57 Million | 122.98 Million |
| Earnings before Tax | 40.36 Million | -284.6 Million | -795.39 Million | -1.53 Billion | -959.14 Million | -4.63 Billion |
| Net Income | 41.57 Million | 75.32 Million | 449.2 Million | -1.09 Billion | -1 Billion | -4.67 Billion |
| Earnings Per Share Basic | 0.07 | -0.45 | -1.15 | -2.24 | -2.07 | -9.66 |
| Earnings Per Share Diluted | 0.07 | -0.45 | -1.15 | -2.24 | -2.07 | -9.66 |
| Weighted Average Shares Outstanding | 626.04 Million | 606.24 Million | 488.36 Million | 487.44 Million | 483.41 Million | 483.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 626.04 Million | 606.24 Million | 488.36 Million | 487.44 Million | 483.41 Million | 483.41 Million |
| Gross Margin | 0.36 | 0.39 | 0.41 | 0.42 | 0.46 | 0.43 |
| EBIT Margin | 0.07 | -0.06 | -0.07 | 0.00 | 0.13 | 0.03 |
| Profit Margin | 0.03 | 0.05 | 0.29 | -0.49 | -0.14 | -0.84 |
| EBITDA | 109.89 Million | -140.08 Million | -241.36 Million | -389.98 Million | -759.84 Million | -1.04 Billion |
| Earnings Before Tax Margin | 0.08 | -0.15 | -0.20 | -0.20 | -0.01 | -0.76 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 734.49 Million | 1.47 Billion | 367.24 Million | 737.55 Million | 368.77 Million | 1.53 Billion |
| Cost of Revenue | 451.77 Million | 943.91 Million | 225.61 Million | 492.14 Million | 217.81 Million | 930.9 Million |
| Gross Profit | 282.72 Million | 528.13 Million | 141.63 Million | 245.41 Million | 150.95 Million | 604.53 Million |
| Operating Expenses | 238.19 Million | 404.46 Million | 142.27 Million | 166.27 Million | 127.11 Million | 784.82 Million |
| Selling, General and Administrative Expenses | 226.51 Million | - | 119.5 Million | 166.27 Million | 111.48 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -11.67 Million | - | 22.77 Million | - | - | 3.57 Million |
| Cost and Expenses | 689.96 Million | 1.34 Billion | 367.89 Million | 658.41 Million | 344.93 Million | 1.71 Billion |
| Operating Income | 44.53 Million | 123.66 Million | -645 Thousand | 79.13 Million | 39.71 Million | -226 Million |
| Interest Expense | 7.33 Million | 12.47 Million | - | 5.14 Million | - | 62.46 Million |
| Income Tax Expense | 1.19 Million | -1.2 Million | 595.5 Thousand | -2.39 Million | 1.19 Million | 1.63 Million |
| Earnings before Tax | -21.04 Million | 40.36 Million | -10.52 Million | 61.41 Million | 30.7 Million | -284.6 Million |
| Net Income | -22.23 Million | 41.57 Million | -11.11 Million | 63.8 Million | 31.9 Million | 75.32 Million |
| Earnings Per Share Basic | -0.04 | - | -0.02 | 0.10 | 0.05 | - |
| Earnings Per Share Diluted | -0.04 | - | -0.02 | 0.10 | 0.05 | - |
| Weighted Average Shares Outstanding | 635.34 Million | 629.84 Million | 626.04 Million | 626.04 Million | 626.04 Million | 606.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 635.34 Million | 629.84 Million | 626.04 Million | 626.04 Million | 626.04 Million | 606.24 Million |
| Gross Margin | 0.38 | 0.36 | 0.39 | 0.33 | 0.41 | 0.39 |
| EBIT Margin | 0.06 | - | -0.08 | 0.18 | 0.15 | - |
| Profit Margin | -0.03 | 0.03 | -0.03 | 0.09 | 0.09 | 0.05 |
| EBITDA | 45.07 Million | - | -29.34 Million | 135.64 Million | 54.9 Million | - |
| Earnings Before Tax Margin | 0.06 | 0.08 | -0.00 | 0.11 | 0.11 | -0.15 |
CMBT
9837
ROYUF
MCY
BAS
IVL